Assessing the safety and efficacy of the ClearRing™ implant for the treatment of benign prostatic hyperplasia in a canine model

Keyphrases

• Canine Model 100%
• Benign Prostatic Hyperplasia 100%
• Dilatation 50%
• Lower Urinary Tract Symptoms 50%
• Transurethral Resection of Prostate 50%
• Urethral Dilatation 50%
• Fever 25%
• Pain Behavior 25%
• Balloon 25%
• Blood Test 25%
• Anesthesia 25%
• Implant Surface 25%
• Clinical Observation 25%
• Implantation Sites 25%
• Prostate 25%
• Fluoroscopy 25%
• Tissue Response 25%
• Minimally Invasive Procedures 25%
• Urethra 25%
• Encrustation 25%
• Nitinol 25%
• Prostate Tissue 25%
• Severe Adverse Events 25%
• Acute Urinary Retention 25%
• C-shaped 25%
• Behavior Disturbance 25%
• Cystoscopy 25%
• Prostatic Urethra 25%
• Gross Hematuria 25%
• Prostatic Hyperplasia 25%
• Prolonged Recovery 25%
• Storage Symptoms 25%
• Voiding Symptoms 25%
• Urinary Test 25%
• Minimally Invasive Device 25%
• Circular Excision 25%

Medicine and Dentistry

• Prostate Hypertrophy 100%
• Implant 40%
• Transurethral Resection 40%
• Urinary System 40%
• Adverse Event 20%
• Body Weight 20%
• Side Effect 20%
• Urinalysis 20%
• Invasive Device 20%
• Incision 20%
• Clinical Observation 20%
• Tissue Reaction 20%
• Balloon Dilatation 20%
• Micturition 20%
• Fluoroscopy 20%
• Nitinol 20%
• Minimally Invasive Procedure 20%
• Cystoscopy 20%
• Urinary Retention 20%
• Microhematuria 20%